The Vanguard of Tomorrow’s Innovations: CLEIO is Redefining Product Development in HealthTech
The Silicon Review
In today’s fast-moving HealthTech landscape, where product development is no longer measured simply by speed but by resilience, compliance, and user-centric design, CLEIO has emerged as a transformative force. Established in 2005 in Trois-Rivières, Quebec, by two visionaries Alexis Bilodeau and Christian Thiffault the firm has risen to prominence as one of North America’s most respected product development companies. Its integrated expertise spans strategy, human factors, design, engineering, software development, and regulatory compliance, all executed under the stringent framework of ISO 13485 certification.
Over two decades, CLEIO has completed more than 2,500 projects, delivering groundbreaking innovations across MedTech, healthcare, industrial, consumer, and cleantech sectors. From designing revolutionary oncology devices for cancer treatment to enhancing cognitive decline detection software and developing connected medical solutions, the firm has consistently pushed the frontier of what’s possible when human needs and advanced technologies are fused.
What distinguishes CLEIO is its holistic approach: projects are guided not only by compliance and engineering rigor but also by empathy, usability, and sustainability. Its philosophy emphasizes connecting the dots between people and technology, ensuring innovations are practical, intuitive, and life-enhancing. Whether supporting ambitious startups or global enterprises, CLEIO has remained steadfast in its mission: to lead change, hand in hand with innovators of tomorrow, and to make a lasting, positive impact on people and the planet.
A Singular Approach to Product Development
At the core of CLEIO’s model lies its multidisciplinary method. Unlike firms that compartmentalize strategy, engineering, and design, CLEIO integrates these domains into a seamless continuum. Human factors engineering and user-centered design form the foundation, ensuring that every product resonates with real-world users. Industrial design and mechanical engineering follow, shaping physical forms into manufacturable solutions. Complementing this is expertise in electronics, software, and firmware, where connected ecosystems and IoT platforms are built with scalability and compliance in mind. This all-in-one structure allows the firm to reduce redundancies, prevent costly missteps, and accelerate time-to-market without compromising safety or quality. The result is a development journey where creativity and compliance are balanced with precision.
MedTech Excellence and Regulatory Discipline
Medical device development requires a balance between innovation and meticulous adherence to regulatory standards. CLEIO has excelled here, leveraging its ISO 13485-certified processes and zero non-conformity record in audits. Its work spans oncology, cardiology, ophthalmology, respiratory care, and digital health ecosystems. Notable projects include the design of Polartrak, a groundbreaking oncology device for Starpax Biopharma, and FreeO2, an oxygen therapy system enabling hospitals to deliver safe, accurate oxygen management. By embedding regulatory compliance into the earliest design stages, CLEIO ensures that products not only innovate but also withstand rigorous market approvals. For healthcare companies navigating the complex regulatory terrain, this dual commitment to creativity and compliance has made the firm indispensable.
Beyond HealthTech: Expanding the Innovation Frontier
While MedTech and healthcare are its anchor sectors, CLEIO has extended its expertise to industrial automation, consumer products, transportation, and cleantech. Examples include automated graders for sawmills, AI-powered navigation devices for the visually impaired, and industrial firefighting cannons. This cross-industry reach fuels a culture of adaptability and broadens the innovation lens through which solutions are developed. By bringing knowledge from one sector into another, CLEIO often achieves breakthrough perspectives. Its work in consumer mobile apps, for instance, informs the usability of medical interfaces, while industrial automation experience enhances precision engineering in healthcare devices.
A Culture Anchored in Values
Innovation at CLEIO is not only a technical pursuit but also a cultural one. The firm’s values transparency, openness, empathy, and surpassing itself are deeply ingrained in its operations. Employees are encouraged to grow beyond their comfort zones, experiment boldly, and collaborate across disciplines. Activities such as CLEIOFest, hackathons, and sports events reinforce a culture of trust, creativity, and camaraderie. The presence of a Chief Happiness Officer underscores the company’s unique commitment to well-being. By fostering an environment that values personal fulfillment alongside professional excellence, CLEIO has built a team culture where passion for technology and human-centered design thrives.
Vision for a Better Tomorrow
At its essence, CLEIO envisions a world where technology is developed not in isolation, but as an extension of human needs and aspirations. The firm remains committed to making a positive impact on people’s health and the environment through every project it undertakes. Whether designing advanced oncology devices or digital platforms for education, the unifying principle is the same: shaping a smarter, healthier, and more sustainable future. For enterprises seeking a trusted partner in product development, CLEIO represents more than an engineering firm it is a catalyst for change, a guardian of compliance, and a champion of innovation that matters.
Alexis Bilodeau, CEO & Co-Founder